Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development program

Panettieri, RA; Wang, M; Braddock, M; Bowen, K; Colice, G

Panettieri, RA (reprint author), Rutgers State Univ, Rutgers Inst Translat Med & Sci, New Brunswick, NJ 08901 USA.

IMMUNOTHERAPY, 2018; 10 (6): 473

Abstract

Tralokinumab, a fully human IgG(4) monoclonal antibody, specifically neutralizes IL-13. The ATMOSPHERE clinical development program comprised four ran......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索